Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Alice Long

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Diabetologia|September 4, 2023
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatmentEmily K Sims, Susan M Geyer, S Alice Long, et al.
International Journal of Cell Biology|October 9, 2015
Regulatory T Cells Resist Cyclosporine-Induced Cell Death via CD44-Mediated Signaling PathwaysShannon M Ruppert, Ben A Falk, S Alice Long, et al.
Journal of Immunological Methods|November 4, 2006
Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversityS Alice Long, Jahan Khalili, Jimiane Ashe, et al.
JCI Insight|March 5, 2019
B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetesPeter S Linsley, Carla J Greenbaum, Cate Speake, et al.
Clinical and Experimental Immunology|May 2, 2024
Impact on in-depth immunophenotyping of delay to peripheral blood processingLauren E Higdon, Sheila Scheiding, Anna M Kus, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2018
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotypeJames D Lord, S Alice Long, Donna M Shows, et al.
Clinical Immunology (Orlando, Fla.)|June 25, 2017
Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation stateKatharine Schwedhelm, Jerill Thorpe, Sara A Murray, et al.
JCI Insight|December 22, 2020
Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjectsKirsten E Diggins, Elisavet Serti, Virginia Muir, et al.
Communications Biology|June 27, 2024
Interconnected lineage trajectories link conventional and natural killer (NK)-like exhausted CD8<sup>+</sup> T cells beneficial in type 1 diabetesErin M Witkop, Kirsten Diggins, Alice Wiedeman, et al.
Clinical Immunology (Orlando, Fla.)|October 31, 2023
Th2 cell clonal expansion at diagnosis in human type 1 diabetesAditi Narsale, Francisco Almanza, Theo Tran, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Diabetologia|September 4, 2023
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatmentEmily K Sims, Susan M Geyer, S Alice Long, et al.
International Journal of Cell Biology|October 9, 2015
Regulatory T Cells Resist Cyclosporine-Induced Cell Death via CD44-Mediated Signaling PathwaysShannon M Ruppert, Ben A Falk, S Alice Long, et al.
Journal of Immunological Methods|November 4, 2006
Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversityS Alice Long, Jahan Khalili, Jimiane Ashe, et al.
JCI Insight|March 5, 2019
B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetesPeter S Linsley, Carla J Greenbaum, Cate Speake, et al.
Clinical and Experimental Immunology|May 2, 2024
Impact on in-depth immunophenotyping of delay to peripheral blood processingLauren E Higdon, Sheila Scheiding, Anna M Kus, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2018
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotypeJames D Lord, S Alice Long, Donna M Shows, et al.
Clinical Immunology (Orlando, Fla.)|June 25, 2017
Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation stateKatharine Schwedhelm, Jerill Thorpe, Sara A Murray, et al.
JCI Insight|December 22, 2020
Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjectsKirsten E Diggins, Elisavet Serti, Virginia Muir, et al.
Communications Biology|June 27, 2024
Interconnected lineage trajectories link conventional and natural killer (NK)-like exhausted CD8<sup>+</sup> T cells beneficial in type 1 diabetesErin M Witkop, Kirsten Diggins, Alice Wiedeman, et al.
Clinical Immunology (Orlando, Fla.)|October 31, 2023
Th2 cell clonal expansion at diagnosis in human type 1 diabetesAditi Narsale, Francisco Almanza, Theo Tran, et al.
Pageof 8